Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder.
Prieto-Conde MI, Labrador J, Hermida G, Alonso S, Jiménez C, García-Álvarez M, Medina A, Balanzategui A, Alcoceba M, Sarasquete ME, Puig N, González V, Gutiérrez NC, García-Sanz R, González-Díaz M, Chillón MDC. Prieto-Conde MI, et al. Among authors: hermida g. Leuk Lymphoma. 2020 Jan;61(1):181-184. doi: 10.1080/10428194.2019.1648801. Epub 2019 Aug 6. Leuk Lymphoma. 2020. PMID: 31385734 No abstract available.
Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'.
Prieto-Conde MI, Labrador J, Hermida G, Alonso S, Jiménez C, García-Alvarez M, Medina A, Balanzategui A, Alcoceba M, Sarasquete ME, Puig N, González V, Gutiérrez NC, García-Sanz R, González-Díaz M, Chillón MDC. Prieto-Conde MI, et al. Among authors: hermida g. Leuk Lymphoma. 2020 Jan;61(1):248-249. doi: 10.1080/10428194.2019.1680843. Epub 2019 Oct 23. Leuk Lymphoma. 2020. PMID: 31642380 No abstract available.
Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse.
Richard C, Baro J, Bello-Fernandez C, Hermida G, Calavia J, Olalla I, Alsar MJ, Loyola I, Cuadrado MA, Iriondo A, et al. Richard C, et al. Among authors: hermida g. Bone Marrow Transplant. 1995 May;15(5):721-6. Bone Marrow Transplant. 1995. PMID: 7670401
33 results